BNET Industries
Market Cap:$40.9M
Last Fiscal Year Sales:$57.0K
- Public
- US
Dow Jones Description
Pharmaceuticals
CFO, Vice President & Treasurer
Stephen B. ThompsonNumber of Employees 9
Contact Information
2600 Stemmons Freeway
Suite 176
Dallas, Texas 75207
(214) 905-5100
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Access Pharmaceuticals files for $25 million public offering
-
OTCPicks.com: ACCP, OGNG, KNDR, CHYU, UNDT, September 10 Daily Market Movers Digest Report from OTCPicks.com
-
OTCPicks.com: ACCP, SNRY, ANPI, YRCW, August 4 Daily Market Movers Digest Report from OTCPicks.com
-
Accessing Access Pharma
-
OTCPicks.com: OOIL, ACCP, RSGR, CBIS, July 27 Daily Market Movers Digest Report from OTCPicks.com
-
Access Pharmaceuticals Announces Commercial Launch of MuGardTM in Norway by SpePharm
-
Why MuGard Will Be Successful
-
Access Pharmaceuticals Announces Commercial Launch of MuGardTM in Greece by SpePharm
News & Analysis
Filter by
access pharmaceuticals inc. - All News and Analysis
Access Pharmaceuticals, Inc. Announces Closing of Private Placement Funding and Implementation of Reverse Stock Split
DALLAS--BW HealthWire--June 18, 1998--Access Pharmaceuticals, Inc. (OTC/BULLETIN BOARD:AXCS) today announced that it has concluded the first closing of a planned financing for up to $7.8 million. Sunrise Securities Corp. is the placement agent for this offering. In this first closing Access raised approximately $2.9 million through the...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Stephen B. Thompson | CFO, Vice President & Treasurer |
| David P. Nowotnik | Senior Vice President, Res |
| Daniel G. Moro | Vice President |
| Gregory J. Russell-Jones | Vice President |
| Maurie Markman | Vice President, Res |
| Phillip Wise | Vice President, Business Development & Strategy |
| Rhone-Poulenc Rorer | Vice President |
| J. Michael Flinn | Director |
| Robert Woolley | Controller |
| Carlos Becerra |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Herbert H. McCade | Board of Directors |
| Herbert H. McDade | Board of Directors |
| J. Michael Finn | Board of Directors |
| Jeffrey B. Davis | Board of Directors |
| John J. Meakem | Board of Directors |
| Mark J. Ahn | Board of Directors |
| Mark J. Alvino | Board of Directors |
| Max Link | Board of Directors |
| Stephen B. Howell | Board of Directors |
| Stuart M. Duty | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | CFO, Vice President & Treasurer | Current |
| Access Pharmaceuticals, Inc. | Vice President, CFO | Current |
| Santa Fe International Corporation | Former |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Senior Vice President, Res | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Vice President, Res | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Vice President, Business Development & Strategy | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Director | Current |
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Lehman Brothers Holdings Inc. | President & Chief Operating Officer | Current |
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Discovery Laboratories, Inc. | Board of Directors | Current |
| Lehman Brothers Holdings Inc. | Global Head, Equities | Former |
| Lehman Brothers Holdings Inc. | Global Head, Fixed Income Division | Former |
| University of Michigan | M.B.A. | Former |
| Duke University | B.A. | Former |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| ESP Pharma, Inc. | Current | |
| Merlin Biosciences Limited | Current | |
| Cell Therapeutics, Inc., Seattle | Current | |
| Alxn | Chairman | Current |
| CytRx Corporation | Chairman | Current |
| Discovery Laboratories, Inc. | Chairman | Current |
| Alexion Pharmaceuticals, Inc. | Board of Directors | Current |
| Columbia Laboratories, Inc. | Board of Directors | Current |
| Sulzer Medica | Board of Directors | Current |
| CytRx Corporation | Board of Directors | Current |
| Discovery Laboratories, Inc. | Board of Directors | Current |
| Human Genome Sciences, Inc. | Board of Directors | Current |
| Celsion Corporation | Board of Directors | Current |
| Cell Therapeutics, Inc. | Board of Directors | Current |
| Centerpulse | Chief Executive Officer | Former |
| Sandoz | President and Chief Executive Officer | Former |
| Celsion Corporation | Chairman, Director | Former |
| Sandoz Pharmaceuticals Corporation | Former | |
| Centerpulse | Chairman | Former |
| PDL BioPharma, Inc. | Chairman | Former |
| Therapeutics Incorporated | Director | Former |
| PDL BioPharma, Inc. | Board of Directors | Former |
| Sandoz | Member of the Executive Board | Former |
| University of St. Gallen | Ph.D. In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Access Pharmaceuticals, Inc. | Board of Directors | Current |
Executive News
-
Access Pharmaceuticals CEO Interviewed on CorporateProfile.com
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


